Ross C. Smith

4.3k total citations
110 papers, 3.2k citations indexed

About

Ross C. Smith is a scholar working on Surgery, Oncology and Physiology. According to data from OpenAlex, Ross C. Smith has authored 110 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Surgery, 39 papers in Oncology and 28 papers in Physiology. Recurrent topics in Ross C. Smith's work include Pancreatic and Hepatic Oncology Research (23 papers), Clinical Nutrition and Gastroenterology (23 papers) and Nutrition and Health in Aging (19 papers). Ross C. Smith is often cited by papers focused on Pancreatic and Hepatic Oncology Research (23 papers), Clinical Nutrition and Gastroenterology (23 papers) and Nutrition and Health in Aging (19 papers). Ross C. Smith collaborates with scholars based in Australia, United Kingdom and New Zealand. Ross C. Smith's co-authors include Graham L. Hill, Barry Allen, Jaswinder S. Samra, Anthony J. Gill, Aiqun Xue, John MacFie, Christopher J. Scarlett, Thomas J. Hugh, M G Ashton and John A. Levi and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Ross C. Smith

109 papers receiving 3.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ross C. Smith 1.0k 981 720 630 627 110 3.2k
Harold O. Douglass 1.5k 1.4× 1.4k 1.4× 1.5k 2.0× 1.3k 2.1× 442 0.7× 70 4.2k
K.‐W. Jauch 787 0.8× 1.5k 1.6× 695 1.0× 551 0.9× 397 0.6× 122 3.1k
Oliver F. Bathe 1.3k 1.3× 1.2k 1.2× 1.1k 1.5× 807 1.3× 166 0.3× 135 3.7k
David A. August 980 0.9× 942 1.0× 528 0.7× 581 0.9× 448 0.7× 126 3.2k
Suguru Yamamoto 419 0.4× 616 0.6× 662 0.9× 754 1.2× 208 0.3× 184 3.5k
Jonathan E. Rhoads 711 0.7× 773 0.8× 267 0.4× 595 0.9× 331 0.5× 70 2.5k
Seiichiro Yamamoto 1.8k 1.7× 377 0.4× 349 0.5× 620 1.0× 297 0.5× 60 4.0k
G. Talamini 2.5k 2.4× 2.7k 2.7× 391 0.5× 1.1k 1.7× 206 0.3× 83 4.8k
Matthew S. Metcalfe 1.1k 1.1× 1.6k 1.6× 130 0.2× 717 1.1× 252 0.4× 122 3.1k
Jervoise Andreyev 2.7k 2.6× 2.2k 2.3× 1.5k 2.0× 1.8k 2.9× 367 0.6× 161 6.9k

Countries citing papers authored by Ross C. Smith

Since Specialization
Citations

This map shows the geographic impact of Ross C. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross C. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross C. Smith more than expected).

Fields of papers citing papers by Ross C. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross C. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross C. Smith. The network helps show where Ross C. Smith may publish in the future.

Co-authorship network of co-authors of Ross C. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Ross C. Smith. A scholar is included among the top collaborators of Ross C. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross C. Smith. Ross C. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xue, Aiqun, Xiaojuan Gong, Sohel M. Julovi, et al.. (2020). Biomimetic Gemcitabine–Lipid Prodrug Nanoparticles for Pancreatic Cancer. ChemPlusChem. 85(6). 1283–1291. 17 indexed citations
3.
Smith, Ross C., Anthony J. Gill, Kerry‐Anne Rye, et al.. (2020). Pancreatic adenocarcinoma preferentially takes up and is suppressed by synthetic nanoparticles carrying apolipoprotein A-II and a lipid gemcitabine prodrug in mice. Cancer Letters. 495. 112–122. 7 indexed citations
4.
Brown, Kai, Aiqun Xue, Sohel M. Julovi, et al.. (2018). Using patient-derived xenograft models of colorectal liver metastases to predict chemosensitivity. Journal of Surgical Research. 227. 158–167. 9 indexed citations
5.
Pang, Tony, Anthony J. Gill, Ross C. Smith, et al.. (2016). A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience. European Journal of Surgical Oncology. 42(10). 1576–1583. 36 indexed citations
6.
Julovi, Sohel M., Aiqun Xue, Anthony J. Gill, et al.. (2016). Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo. PLoS ONE. 11(3). e0151475–e0151475. 19 indexed citations
7.
Smith, Ross C., Jeremy S. Wilson, Callum B. Pearce, et al.. (2015). Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 16(2). 164–180. 54 indexed citations
8.
O’Brien, Darragh P., Neomal S. Sandanayake, Claire Jenkinson, et al.. (2014). Serum CA19-9 Is Significantly Upregulated up to 2 Years before Diagnosis with Pancreatic Cancer: Implications for Early Disease Detection. Clinical Cancer Research. 21(3). 622–631. 147 indexed citations
9.
Wong, Matthew H., Aiqun Xue, Sohel M. Julovi, et al.. (2014). Cotargeting of Epidermal Growth Factor Receptor and PI3K Overcomes PI3K–Akt Oncogenic Dependence in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 20(15). 4047–4058. 33 indexed citations
10.
Baxter, Robert C., et al.. (2014). Factors that May Influence the Willingness of Cancer Patients to Consent for Biobanking. Biopreservation and Biobanking. 12(6). 409–414. 9 indexed citations
11.
Aslani, Alireza, Anthony J. Gill, Paul Roach, Barry Allen, & Ross C. Smith. (2010). Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure. HPB. 12(5). 325–333. 14 indexed citations
12.
Scarlett, Christopher J., et al.. (2005). Assessment of HER-2 Status in Pancreatic Adenocarcinoma. The American Journal of Surgical Pathology. 29(9). 1125–1134. 45 indexed citations
13.
Barratt, Stephen McG, Ross C. Smith, Anthony J. Kee, Laurence E. Mather, & Michael J. Cousins. (2002). Multimodal analgesia and intravenous nutrition preserves total body protein following major upper gastrointestinal surgery☆. Regional Anesthesia & Pain Medicine. 27(1). 15–22. 34 indexed citations
14.
Elliott, Michael, Peter Brady, & Ross C. Smith. (2001). Tracheo‐oesophageal fistula following a fall. ANZ Journal of Surgery. 71(12). 772–773. 7 indexed citations
15.
Hansen, R. D., et al.. (1999). Determination of skeletal muscle and fat-free mass by nuclear and dual-energy X-ray absorptiometry methods in men and women aged 51–84 y. American Journal of Clinical Nutrition. 70(2). 228–233. 73 indexed citations
16.
Smith, Ross C.. (1994). Charity Commission censures British cancer charities. BMJ. 308(6922). 155.2–156. 6 indexed citations
17.
Smith, Ross C., et al.. (1988). Digestive and nutritional status after total gastrectomy with a long Roux‐en‐Y reconstruction. Journal of Gastroenterology and Hepatology. 3(3). 253–259. 2 indexed citations
18.
MacFie, John, Ross C. Smith, & Graham L. Hill. (1981). Glucose or fat as a nonprotein energy source. Gastroenterology. 80(1). 103–107. 15 indexed citations
19.
Smith, Ross C., et al.. (1979). Effect of an elemental diet on body composition. Gastroenterology. 77(4). 652–657. 7 indexed citations
20.
Smith, Ross C., et al.. (1963). Peripheral Neuropathy after Amitriptyline. BMJ. 2(5351). 254.1–254. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harold O. Douglass Breakdown of academic impact, for papers by K.‐W. Jauch Breakdown of academic impact, for papers by Oliver F. Bathe Breakdown of academic impact, for papers by David A. August Breakdown of academic impact, for papers by Suguru Yamamoto Breakdown of academic impact, for papers by Jonathan E. Rhoads Breakdown of academic impact, for papers by Seiichiro Yamamoto Breakdown of academic impact, for papers by G. Talamini Breakdown of academic impact, for papers by Matthew S. Metcalfe Breakdown of academic impact, for papers by Jervoise Andreyev
Rankless by CCL
2026